To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CYB561D2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
224 supporting clones for gene CYB561D2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR612474 Placenta Cot 25-normalized .a 1 to 1212 1 to 1212 exact tiling clone,   1212/1212
(100 %)
0 diff
(100 %id)
CR598666 Placenta Cot 25-normalized .b 1 to 1533 1 to 1533 exact tiling clone,   1533/1533
(100 %)
0 diff
(100 %id)
AL552018 placenta, Placenta Cot 25-normalized .b 1 to 737 1 to 734   fully sequenced,   734/734
(100 %)
6 diff
(99.2 %id)
R61434 whole brain .b 25 to 372 1 to 348     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 348/348
(100 %)
9 diff
(97.5 %id)
BE898556 adenocarcinoma cell line, ovary .b 55 to 850 1 to 786       786/968
(81 %)
25 diff
(97.5 %id)
BG248161 adenocarcinoma cell line, colon .b 340 to 996 1 to 672       672/953
(70 %)
45 diff
(95.3 %id)
BI818208 pooled brain, lung, testis .b 371 to 1050 1 to 679       679/681
(99 %)
12 diff
(98.3 %id)
TI_57196198   .b 371 to 1050 31 to 709       679/711
(95 %)
17 diff
(97.7 %id)
CA488810   .b 375 to 948 1 to 578       578/1118
(51 %)
6 diff
(99.5 %id)
AL575454 placenta, Placenta Cot 25-normalized .b 707 to 1505 820 to 24   fully sequenced,   797/820
(97 %)
3 diff
(99.7 %id)
R61389 whole brain .b 997 to 1564 602 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 592/592
(100 %)
22 diff
(96.3 %id)
AL554667 placenta, Placenta Cot 25-normalized .c 1 to 392 1 to 393   tiling clone, fully sequenced,   393/393
(100 %)
4 diff
(99.0 %id)
CA454269   .c 20 to 859 1 to 854       854/857
(99 %)
18 diff
(97.9 %id)
BC047691 Pancreas, epithelioid carcinoma .c 22 to 1219 1 to 1198 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1198/1198
(100 %)
0 diff
(100 %id)
NM_007022.3   .c 22 to 1219 1 to 1198 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1198/1198
(100 %)
0 diff
(100 %id)
BQ222076 epithelioid carcinoma, Pancreas .c 24 to 896 1 to 886       886/893
(99 %)
19 diff
(97.9 %id)
AK291167   .c 31 to 1222 1 to 1192 exact     1192/1192
(100 %)
0 diff
(100 %id)
BG425916 Kidney .c 31 to 441 1 to 416       416/955
(43 %)
10 diff
(99.0 %id)
DC370916   .c 31 to 545 1 to 515       515/515
(100 %)
0 diff
(100 %id)
CN354152 embryonic stem cells, cell lines H1, H7, andH9 .c 39 to 623 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
AA203295 liver and spleen .c 40 to 617 1 to 565       565/862
(65 %)
14 diff
(98.4 %id)
TI_57150499   .c 42 to 945 28 to 941 G124R L125A L126A A127G V128C ...     910/961
(94 %)
31 diff
(96.8 %id)
BI762601 pooled colon, kidney, stomach .c 46 to 945 1 to 910 G124R L125A L126A A127G V128C ...     910/930
(97 %)
27 diff
(97.1 %id)
BI832104 brain, medulla .c 52 to 685 34 to 691       658/691
(95 %)
41 diff
(94.1 %id)
TI_57174713   .c 52 to 685 34 to 691       658/691
(95 %)
41 diff
(94.1 %id)
BM714950 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 53 to 552 1 to 500       500/500
(100 %)
0 diff
(100 %id)
N79667 multiple sclerosis lesions .c 102 to 546 1 to 455       453/474
(95 %)
27 diff
(94.4 %id)
EL734572 mixed .c 232 to 871 1 to 640       640/640
(100 %)
2 diff
(99.7 %id)
TI_1948211309   .c 232 to 814 134 to 716       583/1356
(42 %)
8 diff
(99.5 %id)
TI_1948211588   .c 232 to 578 133 to 479   fully sequenced,   347/376
(92 %)
6 diff
(98.5 %id)
TI_1948211866   .c 232 to 899 133 to 800       668/1388
(48 %)
20 diff
(98.6 %id)
CR740263   .c 283 to 776 8 to 529       486/529
(91 %)
44 diff
(91.7 %id)
BI088526 cervix .c 338 to 1091 1 to 752       752/752
(100 %)
6 diff
(99.3 %id)
AL577397 placenta, Placenta Cot 25-normalized .c 362 to 1208 848 to 1   fully sequenced,   848/848
(100 %)
16 diff
(98.2 %id)
TI_1948211589   .c 548 to 906 473 to 115   fully sequenced,   359/473
(75 %)
12 diff
(97.5 %id)
N63989 multiple sclerosis lesions .c 774 to 1219 450 to 1       450/450
(100 %)
5 diff
(98.9 %id)
CD622866   .d 1 to 186 18 to 203   tiling clone,   186/210
(88 %)
1 diff
(99.6 %id)
BM563741 brain, medulla .d 104 to 883 1 to 780   tiling clone,   780/1046
(74 %)
16 diff
(98.5 %id)
AA421315   .d 105 to 310 1 to 200       200/200
(100 %)
8 diff
(96.0 %id)
BG288689 bladder, transitional cell papilloma, cell line .d 250 to 948 1 to 688       688/922
(74 %)
23 diff
(97.6 %id)
AF040704   .d 286 to 1402 1 to 1117 exact tiling clone,   1117/1117
(100 %)
1 diff
(100.0 %id)
CA454756   .d 287 to 996 29 to 744       716/883
(81 %)
17 diff
(98.1 %id)
BP263927 small intestine .d 292 to 873 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AA455330 germinal center B cell .d 293 to 727 1 to 431       431/431
(100 %)
4 diff
(99.1 %id)
CV570848 cornea, eye .d 293 to 905 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
DA828603 placenta .d 294 to 890 2 to 600   capped   599/599
(100 %)
10 diff
(98.4 %id)
CN354155 embryonic stem cells, cell lines H1, H7, andH9 .d 301 to 969 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
AA371689 pituitary gland .d 304 to 578 1 to 275       275/275
(100 %)
0 diff
(100 %id)
TI_57148390   .d 304 to 1169 38 to 903 Y216F     866/903
(95 %)
9 diff
(99.1 %id)
BF679835 Prostate .d 305 to 1009 1 to 710       710/977
(72 %)
23 diff
(97.7 %id)
AA448511   .d 306 to 662 1 to 353       353/353
(100 %)
7 diff
(98.1 %id)
BX280610 pooled colon, kidney, stomach .d 311 to 790 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
BI759708 pooled colon, kidney, stomach .d 311 to 1169 1 to 859 Y216F     859/859
(100 %)
4 diff
(99.6 %id)
BU166734 melanotic melanoma, skin .d 313 to 1134 1 to 835 V205G I206H M207Y N208E Q209T ...     835/902
(92 %)
22 diff
(97.6 %id)
BF172279 blood .d 319 to 692 1 to 364       364/367
(99 %)
14 diff
(96.2 %id)
CA488481   .d 324 to 1172 1 to 857 exact     857/929
(92 %)
13 diff
(98.7 %id)
CN354154 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 330 to 1023 1 to 694       694/694
(100 %)
4 diff
(99.5 %id)
CA488429   .d 338 to 1183 1 to 863 G137X G138W V139G G140W L141G ...     863/925
(93 %)
23 diff
(97.6 %id)
AA456453 ovarian tumor, ovary .d 343 to 813 1 to 471       471/471
(100 %)
0 diff
(100 %id)
CR995517 T-Lymphocytes .d 345 to 1114 1 to 771 G138W V139G L141A L142A Y143L ...     771/779
(98 %)
3 diff
(99.7 %id)
BG171664 hypernephroma, cell line, Kidney .d 346 to 1126 1 to 776 F33L V34W A35L V36C A38P ...     776/776
(100 %)
17 diff
(97.9 %id)
BE906077 epithelioid carcinoma, Pancreas .d 355 to 1112 1 to 746 V104S I105S L106S H107T E109S ...     746/925
(80 %)
18 diff
(98.1 %id)
BU164567 epithelioid carcinoma, Pancreas .d 368 to 1220 1 to 870 Q134H C135A S136X G137X G138X ...     870/886
(98 %)
58 diff
(93.5 %id)
TI_149312687   .d 580 to 1411 906 to 90   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 817/949
(86 %)
20 diff
(97.9 %id)
TI_149298719   .d 584 to 1411 901 to 77   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 825/947
(87 %)
16 diff
(98.4 %id)
TI_149315194   .d 589 to 1411 906 to 82   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 825/1047
(78 %)
37 diff
(96.5 %id)
TI_154109294   .d 589 to 1411 898 to 81   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 818/972
(84 %)
8 diff
(99.2 %id)
AA235161.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 596 to 762 1 to 167     also hits gene RNF38 167/167
(100 %)
0 diff
(100 %id)
TI_159722770   .d 614 to 1416 887 to 87   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 801/988
(81 %)
0 diff
(100 %id)
AW025085 Kidney .d 617 to 1414 799 to 1       799/800
(99 %)
51 diff
(93.7 %id)
BY996825   .d 629 to 1263 10 to 645       636/645
(98 %)
6 diff
(99.1 %id)
BM724923 eye, fetal eye .d 632 to 1346 1 to 713       713/713
(100 %)
2 diff
(99.8 %id)
TI_154038891   .d 637 to 1433 847 to 60       788/849
(92 %)
0 diff
(100 %id)
BI861618 breast, mammary adenocarcinoma, cell line .d 642 to 1404 1 to 766   AAA   766/773
(99 %)
8 diff
(99.0 %id)
TI_57192548   .d 642 to 1404 54 to 819   AAA   766/773
(99 %)
8 diff
(99.0 %id)
CD366296 Alveolar Macrophage, lung .d 647 to 1411 784 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 768/768
(100 %)
6 diff
(99.3 %id)
AI738653 colon, colon tumor, RER+ .d 652 to 1404 745 to 1       745/750
(99 %)
15 diff
(98.0 %id)
AI738716 colon, colon tumor, RER+ .d 652 to 1419 767 to 1       767/767
(100 %)
8 diff
(99.0 %id)
CK725177 Chondrosarcoma, Left Pubic Bone .d 655 to 1411 775 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 757/757
(100 %)
1 diff
(99.9 %id)
AI094837 brain, glioblastoma (pooled) .d 659 to 1411 791 to 38   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 754/755
(99 %)
43 diff
(94.4 %id)
AI627263 Kidney .d 664 to 1404 746 to 9       738/749
(98 %)
0 diff
(100 %id)
CA308873 Alveolar Macrophage, lung .d 668 to 1411 761 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 743/743
(100 %)
2 diff
(99.8 %id)
AI479716 anaplastic oligodendroglioma, brain .d 676 to 1419 763 to 27   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 737/737
(100 %)
30 diff
(96.0 %id)
EL952735 eyeball .d 713 to 1157 1 to 444       444/444
(100 %)
6 diff
(98.7 %id)
BM978239 lung .d 725 to 1411 703 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 685/685
(100 %)
4 diff
(99.5 %id)
CA447785 Chondrosarcoma, Left Pelvis .d 734 to 1411 695 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
BM829861 stomach .d 738 to 1376 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BU632749 cell lines, Chondrosarcoma .d 747 to 1411 683 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 665/665
(100 %)
0 diff
(100 %id)
BM975426 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 748 to 1411 681 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
CA306228 Alveolar Macrophage, lung .d 748 to 1411 681 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
BM676657 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 757 to 1411 673 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 655/655
(100 %)
2 diff
(99.7 %id)
AI955686 adenocarcinoma, Pancreas .d 775 to 1409 634 to 1       634/638
(99 %)
9 diff
(98.6 %id)
CA444879 lung, Metastatic Chondrosarcoma .d 775 to 1411 654 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 636/636
(100 %)
2 diff
(99.7 %id)
AA872198 germinal center B cell .d 781 to 1411 642 to 12   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 631/631
(100 %)
8 diff
(98.8 %id)
AI799615 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 784 to 1411 628 to 1       628/628
(100 %)
1 diff
(99.9 %id)
AI479872 anaplastic oligodendroglioma, brain .d 787 to 1413 626 to 1       626/626
(100 %)
2 diff
(99.7 %id)
AI082226 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 788 to 1411 625 to 1       625/628
(99 %)
5 diff
(99.3 %id)
AA977529 Kidney .d 833 to 1415 583 to 1       583/584
(99 %)
4 diff
(99.4 %id)
AI040648 liver and spleen .d 841 to 1411 569 to 1       569/569
(100 %)
8 diff
(98.6 %id)
CA503262 Human Lung Epithelial cells, lung .d 852 to 1419 585 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 568/568
(100 %)
0 diff
(100 %id)
AW014886   .d 863 to 1411 566 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 549/549
(100 %)
0 diff
(100 %id)
AI202135 anaplastic oligodendroglioma, brain .d 866 to 1420 554 to 1       554/609
(90 %)
15 diff
(97.6 %id)
BG231733 blood, lymphocyte .d 871 to 1418 548 to 1       548/548
(100 %)
0 diff
(100 %id)
AI565974 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 873 to 1415 542 to 1       542/542
(100 %)
9 diff
(98.4 %id)
BE729298 melanotic melanoma, skin .d 889 to 1415 1 to 528       528/742
(71 %)
2 diff
(99.8 %id)
BF338784 brain, glioblastoma with EGFR amplification .d 890 to 1411 1 to 522   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 522/522
(100 %)
0 diff
(100 %id)
AA886358 Kidney .d 897 to 1416 521 to 1       521/544
(95 %)
32 diff
(94.2 %id)
CN479270 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 910 to 1411 520 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 502/502
(100 %)
1 diff
(99.9 %id)
AW264820 lung, two pooled squamous cell carcinomas .d 913 to 1419 508 to 1       508/508
(100 %)
4 diff
(99.3 %id)
AI095043 brain, glioblastoma (pooled) .d 919 to 1412 494 to 1       494/494
(100 %)
1 diff
(99.8 %id)
AI199576 anaplastic oligodendroglioma, brain .d 919 to 1417 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
AA447529   .d 923 to 1415 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
EC472176 Prostate .d 925 to 1006 1 to 82       82/82
(100 %)
0 diff
(100 %id)
BU179244 melanotic melanoma, cell line, skin .d 930 to 1411 1 to 482   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 482/482
(100 %)
0 diff
(100 %id)
AI151004 brain, glioblastoma (pooled) .d 931 to 1411 499 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 481/481
(100 %)
5 diff
(99.0 %id)
BE550419 pooled germ cell tumors .d 931 to 1411 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI285202 adenocarcinoma, colon .d 932 to 1427 498 to 3   tiling clone,   496/499
(99 %)
0 diff
(100 %id)
AA807710 germinal center B-cells, tonsil .d 935 to 1411 493 to 17   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 477/477
(100 %)
0 diff
(100 %id)
AI371881 brain, glioblastoma (pooled) .d 937 to 1411 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
AA766548 germinal center B cell .d 941 to 1417 484 to 4       481/484
(99 %)
0 diff
(100 %id)
AI073687 senescent fibroblast .d 945 to 1417 473 to 2       472/473
(99 %)
0 diff
(100 %id)
BU739316 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 945 to 1411 485 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
BG150490 pooled germ cell tumors .d 947 to 1411 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI128861 senescent fibroblast .d 952 to 1087 136 to 1       136/136
(100 %)
2 diff
(98.6 %id)
R15090 whole brain .d 955 to 1417 480 to 4       477/481
(99 %)
0 diff
(100 %id)
AW768432 lymph node, lymphoma, follicular mixed small and largecell .d 956 to 1411 453 to 1       453/453
(100 %)
9 diff
(98.1 %id)
AI762121 Kidney .d 958 to 1411 455 to 1       455/455
(100 %)
22 diff
(95.2 %id)
AA923491 Kidney .d 964 to 1411 447 to 1       447/447
(100 %)
2 diff
(99.6 %id)
AA454950 germinal center B cell .d 970 to 1411 442 to 1       442/442
(100 %)
0 diff
(100 %id)
AI580511 Kidney .d 973 to 1415 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AA454561 ovarian tumor, ovary .d 981 to 1411 431 to 1       431/431
(100 %)
0 diff
(100 %id)
CA310735 Human Lung Epithelial cells, lung .d 985 to 1411 445 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
AA426548 ovarian tumor, ovary .d 996 to 1411 416 to 1       416/416
(100 %)
0 diff
(100 %id)
T03780   .d 998 to 1411 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
BM849656 stomach .d 1000 to 1392 1 to 393   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
AA781260 parathyroid gland, parathyroid tumor .d 1010 to 1419 423 to 14   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 410/410
(100 %)
2 diff
(99.6 %id)
AA477130.
matches multiple genes
ovarian tumor, ovary .d 1010 to 1411 402 to 1     also hits gene SNED1 402/402
(100 %)
0 diff
(100 %id)
AA235070 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1011 to 1411 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AI916865 pooled germ cell tumors .d 1016 to 1411 396 to 1       396/396
(100 %)
6 diff
(98.5 %id)
AW014075   .d 1016 to 1411 413 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 396/398
(99 %)
6 diff
(98.5 %id)
DB373174 placenta .d 1020 to 1411 392 to 1       392/392
(100 %)
3 diff
(99.3 %id)
AI278560 adenocarcinoma, colon .d 1028 to 1411 416 to 33   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 384/384
(100 %)
11 diff
(97.2 %id)
AI571071 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1028 to 1414 386 to 1       386/393
(98 %)
4 diff
(99.0 %id)
AI916880 pooled germ cell tumors .d 1028 to 1413 387 to 1       387/395
(97 %)
1 diff
(99.8 %id)
AI635352 pooled germ cell tumors .d 1057 to 1411 355 to 1       355/355
(100 %)
0 diff
(100 %id)
BE466017 pooled germ cell tumors .d 1057 to 1411 355 to 1       355/355
(100 %)
0 diff
(100 %id)
BM713526 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1061 to 1392 1 to 331   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 331/331
(100 %)
1 diff
(99.7 %id)
AI272098 Kidney .d 1071 to 1411 341 to 1       341/350
(97 %)
0 diff
(100 %id)
BE697717 colon .d 1073 to 1378 1 to 306       306/310
(98 %)
5 diff
(98.4 %id)
AA421268   .d 1081 to 1414 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AI474768 Kidney .d 1093 to 1411 319 to 1       319/319
(100 %)
0 diff
(100 %id)
BQ225414 epithelioid carcinoma, Pancreas .d 1095 to 1411 1 to 317   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
BG978357 colon_ins .d 1108 to 1337 19 to 248       230/248
(92 %)
6 diff
(97.6 %id)
BQ224234 melanotic melanoma, skin .d 1124 to 1419 12 to 307   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 296/307
(96 %)
6 diff
(98.1 %id)
F20845 pectoral muscle (after mastectomy) .d 1125 to 1376 1 to 254       254/254
(100 %)
2 diff
(99.3 %id)
AA732236 germinal center B cell .d 1125 to 1345 220 to 1       220/231
(95 %)
1 diff
(99.6 %id)
AA678113 liver and spleen .d 1155 to 1423 269 to 1       269/269
(100 %)
3 diff
(98.9 %id)
W86852 liver and spleen .d 1189 to 1423 236 to 1   tiling clone,   236/236
(100 %)
1 diff
(99.6 %id)
AI469484 colon, moderately-differentiated adenocarcinoma .d 1202 to 1411 210 to 1       210/210
(100 %)
0 diff
(100 %id)
AI424615 brain, glioblastoma (pooled) .d 1208 to 1411 204 to 1       204/204
(100 %)
0 diff
(100 %id)
BE327837 malignant melanoma, metastatic to lymphnode, skin .d 1233 to 1410 180 to 1       180/180
(100 %)
5 diff
(97.3 %id)
AW591473 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1251 to 1411 162 to 1       162/162
(100 %)
1 diff
(99.4 %id)
FN137325 breast carcinoma .d 1280 to 1347 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
EC479632 Prostate .d 1285 to 1353 1 to 68       68/80
(85 %)
3 diff
(96.3 %id)
FN156662 breast carcinoma .d 1333 to 1392 1 to 59       59/59
(100 %)
1 diff
(98.4 %id)
BX641103 human salivary gland .e-u 1 to 3207 1 to 3210 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3210/3210
(100 %)
5 diff
(99.9 %id)
BI912362 leukocyte .e-u 23 to 679 1 to 658       658/660
(99 %)
15 diff
(97.8 %id)
TI_57235600   .e-u 23 to 679 1 to 658       658/660
(99 %)
15 diff
(97.8 %id)
R25004 whole brain .e-u 26 to 375 1 to 361       361/384
(94 %)
21 diff
(94.6 %id)
AA369738 Pancreas .e-u 36 to 379 1 to 345       345/345
(100 %)
7 diff
(98.0 %id)
DA738895   .e-u 37 to 587 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
AA295340 Pancreas .e-u 51 to 272 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
DA955974 Spleen .e-u 355 to 912 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA118631 cerebellum .f 1 to 340 2 to 341   tiling clone, capped   340/340
(100 %)
0 diff
(100 %id)
AA394008.
matches multiple genes
  .f 219 to 620 1 to 399     also hits gene blawgloby 399/399
(100 %)
6 diff
(98.5 %id)
AA255807 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 232 to 631 13 to 409       397/409
(97 %)
6 diff
(98.6 %id)
DA375678 thalamus .f 257 to 719 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
T16903   .f 290 to 629 16 to 355       340/359
(94 %)
4 diff
(98.9 %id)
Z45995 brain, total brain .f 294 to 511 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
CB142328 Liver .f 299 to 690 1 to 392       392/392
(100 %)
0 diff
(100 %id)
CT000022 T-Lymphocytes .f 311 to 939 1 to 629   tiling clone,   629/629
(100 %)
1 diff
(99.9 %id)
AA256700 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1101 to 1219 119 to 1   tiling clone,   119/122
(97 %)
0 diff
(100 %id)
BP273508   .g 1 to 407 2 to 408 Y12F G17V G18* tiling clone,   408/577
(70 %)
5 diff
(99.2 %id)
BM852873 Ascites, stomach .h 1 to 485 1 to 485 exact tiling clone,   485/485
(100 %)
0 diff
(100 %id)
AU099948   .h 183 to 359 124 to 300       177/300
(59 %)
10 diff
(96.7 %id)
BF172468 blood .h 294 to 371 1 to 78       78/116
(67 %)
1 diff
(99.2 %id)
AI094263 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1 to 452 450 to -5 W10* tiling clone,   449/452
(99 %)
2 diff
(99.6 %id)
AA435601.
matches multiple genes
  .i 31 to 452 425 to 4     also hits gene mucharby 422/425
(99 %)
0 diff
(100 %id)
BU730514 eye, RPE and Choroid .i 212 to 452 260 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 242/242
(100 %)
1 diff
(99.6 %id)
AI659172 Prostate .i 218 to 452 235 to 1   tiling clone,   235/235
(100 %)
0 diff
(100 %id)
CA314714 Human Lung Epithelial cells, lung .i 221 to 452 249 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 231/231
(100 %)
1 diff
(99.6 %id)
AI272924 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 222 to 451 231 to 1       231/440
(52 %)
2 diff
(99.6 %id)
CA312144 Human Lung Epithelial cells, lung .i 222 to 452 249 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 231/231
(100 %)
0 diff
(100 %id)
BF509933   .i 223 to 452 247 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 230/233
(98 %)
2 diff
(99.2 %id)
AI373467 Kidney .i 226 to 452 227 to 1       227/228
(99 %)
1 diff
(99.6 %id)
AI867485 Prostate .i 233 to 452 224 to 5       220/224
(98 %)
0 diff
(100 %id)
AW089031 ovary, tumor, 5 pooled (see description) .i 236 to 452 218 to 1       218/218
(100 %)
1 diff
(99.6 %id)
T16902   .i 253 to 452 200 to 1       200/200
(100 %)
1 diff
(99.5 %id)
AW149205 Kidney, renal cell tumor .i 265 to 452 188 to 1       188/191
(98 %)
0 diff
(100 %id)
DB128192 thymus .j 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
BM925473 brain .j 33 to 750 10 to 727   tiling clone,   718/753
(95 %)
6 diff
(99.3 %id)
DA374939 thalamus .j 41 to 588 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA865934 Prostate .j 41 to 578 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA946746 Spleen .j 41 to 605 2 to 566   capped   565/566
(99 %)
1 diff
(99.9 %id)
DB154735 thymus .j 41 to 606 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AA524493 colon .j 515 to 1045 529 to 3 R76M tiling clone,   527/529
(99 %)
3 diff
(99.5 %id)
BE221870 Kidney .j 607 to 1043 454 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 437/437
(100 %)
17 diff
(96.2 %id)
EL952756 eyeball .k 1 to 508 1 to 508 exact tiling clone,   508/508
(100 %)
3 diff
(99.5 %id)
BM694357 eye, RPE and Choroid .l 1 to 565 1 to 568 P11X T35N N37E P38S P39S ...     568/568
(100 %)
4 diff
(99.3 %id)
BM704874 eye, RPE and Choroid .l 1 to 590 1 to 590 P11X tiling clone,   590/590
(100 %)
0 diff
(100 %id)
R60736 whole brain .l 36 to 415 1 to 381     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 381/381
(100 %)
2 diff
(99.5 %id)
H11152 whole brain .l 36 to 491 1 to 458     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 458/484
(94 %)
14 diff
(97.2 %id)
CB051008 Prostate .l 52 to 374 10 to 332     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 323/332
(97 %)
6 diff
(98.2 %id)
H11064 whole brain .l 541 to 942 411 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 401/482
(83 %)
13 diff
(97.4 %id)
R60737 whole brain .l 560 to 942 403 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 393/393
(100 %)
58 diff
(85.3 %id)
CB051007 Prostate .l 731 to 939 229 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
BI906810 leukocyte .m 1 to 835 7 to 839       839/840
(99 %)
9 diff
(99.0 %id)
TI_57233281   .m 1 to 835 37 to 869       839/870
(96 %)
13 diff
(98.6 %id)
DB047325 testis .m 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
R92257 liver and spleen .m 337 to 741 1 to 407       407/410
(99 %)
11 diff
(97.4 %id)
CB115721 Liver .m 361 to 863 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
CB122031 Liver .m 361 to 796 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
CB123931 Liver .m 361 to 750 1 to 390       390/390
(100 %)
2 diff
(99.5 %id)
CB148040 Liver .m 376 to 869 1 to 494   tiling clone,   494/494
(100 %)
0 diff
(100 %id)
CB146893 Liver .m 376 to 869 1 to 494       494/494
(100 %)
6 diff
(98.8 %id)
TI_154103522   .m 465 to 1505 1110 to 79 S9L T59X tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1032/1035
(99 %)
15 diff
(98.6 %id)
DB338299 testis .m 982 to 1513 532 to 1   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
CN354156 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 1 to 631 5 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
BG506845 lung .n 1 to 815 3 to 818 C37V A38C L39T L40X L42P ... tiling clone,   818/818
(100 %)
38 diff
(95.4 %id)
BG436739 large cell carcinoma, lung .o 1 to 708 1 to 708 exact tiling clone,   708/708
(100 %)
3 diff
(99.6 %id)
FN092151 breast carcinoma .o 11 to 92 1 to 82       82/82
(100 %)
5 diff
(94.0 %id)
DA868036 Prostate .p-u 1 to 536 2 to 537 exact tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
T17299   .q 1 to 511 505 to 1 G21X tiling clone,   505/505
(100 %)
18 diff
(96.5 %id)
CN354151 embryonic stem cells, DMSO-treated H9 cellline Gene CYB561D2, variant not shown         Suspected internal deletion, this clone was ignored    
EC494321 Prostate Gene CYB561D2, variant not shown         This clone was ignored    
EC520289 Prostate Gene CYB561D2, variant not shown         This clone was ignored    
AW051794 brain, glioblastoma (pooled) Gene CYB561D2, variant not shown         Suspected internal deletion, this clone was ignored    
BE857589 brain, glioblastoma (pooled) Gene CYB561D2, variant not shown         Suspected internal deletion, this clone was ignored    
DB121628 thymus Gene CYB561D2, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI